The topic has been discussed briefly in posts over the last few months and the general consensus seems to be that it would be more likely for individual treatments being bought out as opposed to the whole company being taken over. However I can't see this happening till they are a little further along the development process.
Are there really many other companies out there that would be interested in our WHOLE portfolio of possible treatments with the cash to boot?
Either way, if there were to be a buyout at all this year I hope the BOD make it a little sweeter for us than the recent cap raise!
GLAH
General discussion, page-15035
-
- There are more pages in this discussion • 5,072 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)